Table 3.
Characteristics | No. of Patients |
---|---|
Nodular Sclerosis (NS) | 100 |
Male | 53 |
Age | 33 (17–81) |
Treatment | |
Combined modality | 100% |
Mixed Cellularity (MC) | 23 |
Male | 15 |
Age | 39 (19–69) |
Treatment | |
Combined modality | 100% |
Characteristics | No. of Patients |
---|---|
Nodular Sclerosis (NS) | 100 |
Male | 53 |
Age | 33 (17–81) |
Treatment | |
Combined modality | 100% |
Mixed Cellularity (MC) | 23 |
Male | 15 |
Age | 39 (19–69) |
Treatment | |
Combined modality | 100% |